Clinical trial NCT03119155: Improvement on Diagnosis of Fetal Congenital Heart Disease Based on Multi-center Collaboration in China
Official title: Improvement on Diagnosis of Fetal Congenital Heart Disease Based on Multi-center Collaboration in China
Study type: OBSERVATIONAL
Overall status: UNKNOWN
Conditions: Congenital Heart Disease
Echocardiography
Diagnosis
Keywords: Congenital Heart Disease
Echocardiography
Diagnosis
Lead sponsor: Beijing Anzhen Hospital
Sponsor class: OTHER
First posted: 2017-04-18
Enrollment: 5000
Sex: FEMALE
Minimum age (years): 18
Maximum age (years): 45
Standard ages: ADULT
Accepts healthy volunteers: no
Observational model: CASE_ONLY
Time perspective: CROSS_SECTIONAL
Sampling method: PROBABILITY_SAMPLE
Study population: Gravidas with singleton pregnancy with congenital heart disease

Brief summary: The objective of this study is to improve the diagnosis level of fetal congenital heart disease by the multi-center collaboration in China.

Detailed description: Our center has constructed multi-center collaborative network in 2013, so far which contains more than 170 maternal and child health care hospitals throughout the whole of China. This is a multi-center-based study to improve the integral diagnostic level of fetal congenital heart diseases by fetal echocardiography. Sixty pregnant cases (18-45 years) whose fetuses with heart abnormalities will be recruited in a successive manner from every center every year. Cases are gravidas with fetal congenital heart disease diagnosed by echocardiography in 16th-24th of gestational weeks. Every center will upload the echocardiography materials and the diagnostic reports so that another two experienced echocardiography physicians confirm the diagnosis based on these materials in a double-blinded method. In addition, the golden standard of congenital heart disease depends on the autopsy, heart and vascular casting after abortion and operation after birth. The investigators will provide the report about the rate of missed diagnosis and misdiagnosis and the periodical training on fetal echocardiography for every center every half an year. Only gravidas who are willing to have complete pregnancy checks and finally delivery or abortion in the hospital are interviewed are eligible for the study. Study participants will be asked for their informed consent.

Eligibility criteria: Inclusion Criteria:

* 1.Gravida with singleton pregnancy with congenital heart disease taking fetal echocardiography in 16th-24nd of gestational weeks.
* 2.Complete pregnancy check in Beijing Anzhen Hospital and the hospitals contained in our multi-center network collaboration, and finally delivery or abortion in these hospitals.
* 3.Willing to cooperate with our study.

Exclusion Criteria:

* 1. Pregnant women with serious pregnancy complications and suffering from mental illness.
* 2.Pregnant women not willing to cooperate

Primary outcomes:
measure: the rate of missed diagnosis and misdiagnosis
timeFrame: From Jan 2018 to Dec 2020
Secondary outcomes:
measure: The prognosis of different type of fetal congenital heart disease with 1 year after birth
timeFrame: From Jan 2018 to Dec 2021
Other outcomes:
Locations:
city: Beijing
country: China
facility: Beijng Anzhen Hospital
state: Beijing
Study officials:
References: